NCT02470767

An Observational Cross-sectional Study Evaluating the Sociodemographic and Clinical Characteristics of Patients Diagnosed With NVAF With a Risk of Stroke or Systemic Embolism, Who Are on Treatment to Adequately Control Their Coagulation and Treated in Primary Care Centres

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 792 (actual)
• Sponsor: Bayer · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

describe the sociodemographic and clinical characteristics of patients diagnosed with non-valvular atrial fibrillation (NVAF) at risk of stroke or systemic embolism on anticoagulant therapy who have changed their therapeutic regimen, due to any clinical situation, based on the doctor's routine clinical practice and are currently on treatment with a direct oral anticoagulant (DOAC)

Conditions

• Stroke
• Prevention and Control
• Atrial Fibrillation

Interventions

Type	Name	Description
DRUG	Direct Oral Anticoagulant (DOAC)	Treatment pattern following the summary of product characteristics

Timeline

• Start date: 2015-05-01
• Primary completion: 2015-12-01
• Completion: 2016-03-01
• First posted: 2015-06-12
• Last updated: 2017-02-16

Locations

1 site across 1 country: Spain